ADAMTS13: An Emerging Target in Stroke Therapy
Authors:
Open Access
- 17 July 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 10, 772
Abstract
Thrombosis is the main pathogenesis of acute ischemic stroke (AIS). The main treatments for stroke either have limited efficacy or increase the risk of bleeding. ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) is a metal protease that can effectively break down VWF (Von Willebrand Factor, VWF), the key factor in thrombus formation. Previous studies have proven that the abnormality of its activity is associated with many diseases. In recent years, it has been found that ADAMTS13 is closely related to stroke. We focus on the relationship between ADAMTS13 and acute ischemic stroke, combining with the structure and function of ADAMTS13 and find that ADAMTS13 is expected to become a new therapeutic target for acute ischemic stroke.Keywords
Funding Information
- Fudan University
- Science and Technology Commission of Shanghai Municipality
This publication has 80 references indexed in Scilit:
- A genome-wide association study identifies a gene network of ADAMTS genes in the predisposition to pediatric strokeBlood, 2012
- ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesisMicrovascular Research, 2012
- Identification of Galectin-1 and Galectin-3 as Novel Partners for Von Willebrand FactorArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factorBlood, 2011
- Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial CellsJournal of Biological Chemistry, 2011
- ADAMTS13 activity and antigen during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcomeHaematologica, 2011
- N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and miceJournal of Clinical Investigation, 2011
- Endothelial von Willebrand factor regulates angiogenesisBlood, 2011
- von Willebrand factor–cleaving protease ADAMTS13 reduces ischemic brain injury in experimental strokeBlood, 2009
- Inherited thrombotic thrombocytopenic purpuraHaematologica, 2009